نتایج جستجو برای: lisinopril dehydrate

تعداد نتایج: 1360  

Journal: :Diabetes care 2000
L Tarnow P Rossing C Jensen B V Hansen H H Parving

OBJECTIVE To compare the long-term effect on kidney function of a long-acting calcium antagonist (nisoldipine) versus a long-acting ACE inhibitor (lisinopril) in hypertensive type 1 diabetic patients with diabetic nephropathy. RESEARCH DESIGN AND METHODS We performed a 4-year prospective, randomized, double-dummy controlled study comparing nisoldipine (20-40 mg once a day) with lisinopril (10...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2014
Rajiv Agarwal Arjun D Sinha Maria K Pappas Terri N Abraham Getachew G Tegegne

BACKGROUND The purpose of this study was to determine among maintenance hemodialysis patients with echocardiographic left ventricular hypertrophy and hypertension whether in comparison with a β-blocker-based antihypertensive therapy, an angiotensin converting enzyme-inhibitor-based antihypertensive therapy causes a greater regression of left ventricular hypertrophy. METHODS Subjects were rand...

Journal: :Bioorganic & medicinal chemistry letters 2006
Aloysius T Nchinda Kelly Chibale Pierre Redelinghuys Edward D Sturrock

With a view to developing a more C-domain-selective angiotensin I-converting enzyme (ACE)-inhibitor, a novel analogue of lisinopril has been synthesized which incorporates a bulky P(2)(') tryptophan functionality. This inhibitor demonstrated a significantly increased specificity for the C-domain as compared with lisinopril. Molecular docking revealed hydrophobic and hydrogen-bonding interaction...

Journal: :Journal of the American Society of Nephrology : JASN 2003
Ariela Benigni Carla Zoja Daniela Corna Cristina Zatelli Sara Conti Marco Campana Elena Gagliardini Daniela Rottoli Cristina Zanchi Mauro Abbate Steve Ledbetter Giuseppe Remuzzi

Renin-angiotensin system (RAS) inhibitors are effective in reducing renal disease progression in early diabetic nephropathy, but they provide imperfect protection at a later stage. Due to the pivotal role of transforming growth factor-beta (TGF-beta) in the pathogenesis of diabetic kidney disease, this study tested the effect of simultaneously interrupting TGF-beta and angiotensin II on disease...

Journal: :Hypertension 2006
Frans H H Leenen Chuke E Nwachuku Henry R Black William C Cushman Barry R Davis Lara M Simpson Michael H Alderman Steven A Atlas Jan N Basile Aloysius B Cuyjet Richard Dart James V Felicetta Richard H Grimm L Julian Haywood Syed Z A Jafri Michael A Proschan Udho Thadani Paul K Whelton Jackson T Wright

The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT) provides a unique opportunity to compare the long-term relative safety and efficacy of angiotensin-converting enzyme inhibitor and calcium channel blocker-initiated therapy in older hypertensive individuals. Patients were randomized to amlodipine (n=9048) or lisinopril (n=9054). The primary outcome was comb...

2007
Gülten TAÇOY Murat ÖZDEMIR Yusuf TAVIL Sedat TÜRKOGLU Atiye ÇENGEL

Gülten TAÇOY, Murat ÖZDEMIR, Yusuf TAVIL, Sedat TÜRKOGLU, Atiye ÇENGEL Gazi Üniversity Medical Faculty, Department of Cardiology, Ankara. SUMMARY Purpose: Afterload reduction decreases volume overload on the left ventricle in chronic asymptomatic aortic regurgitation (AR). In this prospective, randomized trial, we aimed to compare the effects of a 6-months long treatment with lisinopril versus ...

Journal: :Journal of managed care pharmacy : JMCP 2003
Jennifer Wogen Charles A Kreilick Richard C Livornese Krista Yokoyama Feride Frech

OBJECTIVE To compare the persistence and compliance in a usual-care setting with 3 drugs (amlodipine, lisinopril, or valsartan) from 3 different pharmaceutical classes.calcium-channel blocker, angiotensin-converting enzyme inhibitor, and angiotensin receptor blocker, respectively, commonly used to treat hypertension. METHODS This retrospective observational study included a cohort of 142,945 ...

Journal: :Hypertension 1994
M Barenbrock C Spieker A P Hoeks W Zidek K H Rahn

Apart from lowering blood pressure, antihypertensive drugs may influence vessel wall function. In a randomized double-blind study, the effect of lisinopril and metoprolol on arterial distensibility was studied in 40 patients with essential hypertension. After a placebo run-in period, the patients were randomly treated with metoprolol (50, 100, or 200 mg) or lisinopril (5, 10, or 20 mg) for 10 w...

Journal: :Clinical journal of the American Society of Nephrology : CJASN 2015
Panagiotis I Georgianos Rajiv Agarwal

BACKGROUND AND OBJECTIVES Whether improvements in arterial compliance with BP lowering are because of BP reduction alone or if pleiotropic effects of antihypertensive agents contribute remains unclear. It was hypothesized that, among patients on hemodialysis, compared with a β-blocker (atenolol), a lisinopril-based therapy will better reduce arterial stiffness. DESIGN, SETTING, PARTICIPANTS, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید